The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

This publication has 39 references indexed in Scilit:

• Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
• SCLC–State of the Art and What Does the Future Have in Store?
  Clinical Lung Cancer, 2016
• Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
  Journal of Neuro-Oncology, 2016
• Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
  JNCI: Journal of the National Cancer Institute, 2015
• PD-L1 expression in small cell neuroendocrine carcinomas
  European Journal of Cancer, 2015
• Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3⁺ cells in tumour infiltrate
  International Journal of Cancer, 2012
• Survival outcomes with the use of surgery in limited‐stage small cell lung cancer
  Cancer, 2010
• Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
  Immunity, 2009
• A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer
  European Journal of Cardio-Thoracic Surgery, 2004
• Long term results of surgery and chemotherapy in small cell lung cancer1
  European Journal of Cardio-Thoracic Surgery, 1998